Where does Astura Medical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Astura Medical Inc. ranks #12,360 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Astura Medical Inc. hold?

Astura Medical Inc. holds 24 US utility patents granted between 2021 and 2025, spanning 2 technology areas.

What is Astura Medical Inc.'s Innovation Score?

Astura Medical Inc. has an Innovation Score of 45.5 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Astura Medical Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Astura Medical Inc..

What does claim depth mean for Astura Medical Inc.'s patents?

Astura Medical Inc.'s patents average 15.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Astura Medical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Astura Medical Inc.

Q: What technology areas does Astura Medical Inc. focus on?

Astura Medical Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 13 patents, ranking #502 of 3,082 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 24 granted patents across 2 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Astura ranks #12,360 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 2 technology areas.

#12,360
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.5/100): 15.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R12360 · US Corporation #12,360 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 24 grants
UPPER-Q #12,360/49,997
PHOTO-FINISH Arçelik Anonim Sirketi
CPC-NARROW A61F · 2 areas
INNOV-PAR 45.5/100
CLAIMS-RICH 15.7 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Arçelik Anonim Sirketi (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Astura’s 45.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (24%) Velocity 20.0 pts (44%) Breadth 5.0 pts (11%) Claim depth 9.4 pts (21%)

Qualcomm Incorporated · highest

85
Astura Medical · this assignee

46
3D Lighting… · lowest

7

What this shows Astura's Innovation Score is 45.5/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Astura?

Each dot is one of Astura’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Astura’s own 15.7 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Astura vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Astura's grants concentrate

Astura Medical Inc. is a focused PatentsView assignee: 2 CPC subclasses with 54.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (11 grants) versus a trough of 2 in 2021. By volume, Astura sits between Arkade, Inc. and Bluewind Medical Ltd..

Astura's three-year grant acceleration

Astura Medical Inc. shows 15 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Arkade

24
Arçelik Anonim Si…

24
Asahi Kasei Pharma

24
Astera Labs

24
Avantama

24
Babylon Partners

24
Birkenstock Sales

24
Bluewind Medical

24
Astura Medical ◀

24

What this shows Astura holds 24 patents at rank #12,362, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Astura

By rank, the assignees closest to #12,362 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Astura's primary technology class.

Astura's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Astura Medical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	8.3%
2022	2	8.3%
2023	11	45.8%
2024	2	8.3%
2025partial year	7	29.2%

Which technologies does Astura Medical Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 13

A61B - DIAGNOSIS; SURGERY; Identification 11

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Astura Medical Inc.'s patent record in context - here's where to go next.

Astura Medical Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 54.2% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #12,360 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Astura Medical Inc. against Arkade, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.